Results 131 to 140 of about 22,314 (175)

Acute Myeloid Leukemia in the Elderly Patient: New Strategies [PDF]

, 2015

core   +1 more source

Azacitidine as maintenance therapy in pediatric <i>de novo</i> acute myeloid leukemia. [PDF]

Front Immunol
Wu C, Cai C, Li M, Li N, Zheng Y, Zheng H.   +5 more
europepmc   +1 more source

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis. [PDF]

Front Pharmacol
Bica AM, Marcu AD, Jercan CG, Iordan I, Serbanica AN, Avramescu I, Colita M, Popa DC, Constantinescu I, Ichim AM, Colita A, Colita A.   +11 more
europepmc   +1 more source

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report. [PDF]

Am J Case Rep
Shahverdi E, Mundmann P, Pohlkamp C, Dirare S, Hussein Mohamed I, Semerci H, Petz C.   +6 more
europepmc   +1 more source

15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study. [PDF]

Cancers (Basel)
Lai B, Mei C, Yan X, Chen L, Wang Y, Sheng L, Tang S, Mao L, Zhang P, Sun Y, Xie W, Zhou, Mai W, Wang H, Ma L, Lou Y, Wu W, Jiang H, Zhang J, Ye B, Tong H, Ouyang G.   +21 more
europepmc   +1 more source

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation [PDF]

, 2017

core   +1 more source

Azacitidine Beyond the Bone Marrow: An Unexpected Journey Into Azacitidine-Induced Arthropathy. [PDF]

Cureus
Bandyopadhyay S, Sahu A, Kumar Chandra S, Ghosh Dastidar A, Pratihar S.   +4 more
europepmc   +1 more source

ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia. [PDF]

Future Oncol
Vyas P, Salek S, Vives S, Recher C, Döhner H, Venditti A, Derrien H, Chatin S, De La Bigne AM, Pelouchova J, Hills R, Nier S.   +11 more
europepmc   +1 more source

The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. [PDF]

Blood Res
Prajapati S, Jyotishi C, Patel M, Gupta R.   +3 more
europepmc   +1 more source

Quantitative Stability Evaluation of Reconstituted Azacitidine Under Clinical Storage Conditions. [PDF]

Pharmaceuticals (Basel)
Ruga S, Lombardi R, Bocci T, Armenise M, Masullo M, Lamesta C, Bava R, Castagna F, Matarese E, Di Viesti MP, Biancofiore A, Liguori G, Palma E.   +12 more
europepmc   +1 more source